0.1435
-0.0012
(-0.83%)
At close: 5:13:26 PM GMT+2
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Yann M. Duchesne | Executive Chairman | 162k | -- | 1956 |
| Mr. Martin Deterre | GM & CEO | 197.57k | -- | -- |
| Mr. Christophe Lamboeuf | Chief Financial Officer | -- | -- | -- |
| Mr. Gaylord Tallec | Vice President of Operations | -- | -- | -- |
| Jérémie Anquez | VP Research & Chief Scientific Officer | -- | -- | -- |
| Marie Berne | Marketing & Customer Relations Director | -- | -- | -- |
| Mr. Michel Nuta M.D. | VP of Veins & Chief Medical Officer | -- | -- | -- |
Theraclion SA
- Sector:
- Healthcare
- Industry: Medical Devices
- Full Time Employees:
- 28
Description
Theraclion SA designs and markets high-tech therapeutic ultrasound equipment. It offers SONOVEIN, a robotic solution for non-invasive echotherapy treatment of varicose veins; ECHOPULSE, a robotic and non-invasive solution for echotherapy treatment of thyroid nodules and breast fibroadenoma; and EPack, a disposable that is installed on the device before treatment and protects the patient's skin and optimizes the image quality. Theraclion SA was incorporated in 2004 and is based in Malakoff, France.
Corporate Governance
Theraclion SA’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
April 29, 2025 at 10:59 AM UTC
Theraclion SA Earnings Date
Recent Events
Recent Events Information Not Available